This policy provides a framework to assist ICB staff in determining when commercial sponsorship or a joint working agreement with the pharmaceutical industry is appropriate.
It sets out the principles and standards which should be applied when the employees of the ICB or their representatives engage with the pharmaceutical industry.
It is strongly recommended that member practices adopt this policy. It is essential that all projects or dealings with the Pharmaceutical Industry are open and transparent.
For further information please contact the Medicines Optimisation team via email@example.com